Bariatric Surgeries Are Too Drastic and Too Costly to Insure

Susan Farley
Published Online: Saturday, May 1, 2004

The widespread demand for bariatric surgeries has caused health insurers to reevaluate the risks and benefits for their members, and many HMOs are ending coverage or limiting qualifying patients. This cutback comes at a time when the US government has declared obesity a public health crisis, and the number of bariatric procedures performed each year has jumped from approximately 16,000 in the early 1990s to 103,000 last year, according to Robert Steinbrook, MD, a deputy editor of the New England Journal of Medicine.

The $30,000 procedure is considered a lucrative surgery for physicians, and there is increased concern about the number of unqualified doctors performing the surgery. The surgery is recommended for the "morbidly obese," meaning men who are 100 lb overweight and women who are 80 lb overweight?or 4.7% of the US population. Blue Cross and Blue Shield of Florida will end coverage next year. That HMO's Vice President Barry Schwartz, MD, has said that risk, not cost, was the main factor in dropping coverage. He contends that obesity is a condition, not a disease, and can be modified with diet and exercise. Morgan Downey of the American Obesity Association, however, disagrees, calling diet and exercise a "simplistic" remedy. Downey has stated, "The irony is that they're still paying for all the conditions that obesity causes," such as diabetes, hypertension, arthritis, and heart disease.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues